Literature DB >> 23273993

Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

Sarah Schwitalla1, Alexander A Fingerle, Patrizia Cammareri, Tim Nebelsiek, Serkan I Göktuna, Paul K Ziegler, Ozge Canli, Jarom Heijmans, David J Huels, Guenievre Moreaux, Rudolf A Rupec, Markus Gerhard, Roland Schmid, Nick Barker, Hans Clevers, Roland Lang, Jens Neumann, Thomas Kirchner, Makoto M Taketo, Gijs R van den Brink, Owen J Sansom, Melek C Arkan, Florian R Greten.   

Abstract

Cell-type plasticity within a tumor has recently been suggested to cause a bidirectional conversion between tumor-initiating stem cells and nonstem cells triggered by an inflammatory stroma. NF-κB represents a key transcription factor within the inflammatory tumor microenvironment. However, NF-κB's function in tumor-initiating cells has not been examined yet. Using a genetic model of intestinal epithelial cell (IEC)-restricted constitutive Wnt-activation, which comprises the most common event in the initiation of colon cancer, we demonstrate that NF-κB modulates Wnt signaling and show that IEC-specific ablation of RelA/p65 retards crypt stem cell expansion. In contrast, elevated NF-κB signaling enhances Wnt activation and induces dedifferentiation of nonstem cells that acquire tumor-initiating capacity. Thus, our data support the concept of bidirectional conversion and highlight the importance of inflammatory signaling for dedifferentiation and generation of tumor-initiating cells in vivo.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273993     DOI: 10.1016/j.cell.2012.12.012

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  457 in total

1.  Myocardial NF-κB activation is essential for zebrafish heart regeneration.

Authors:  Ravi Karra; Anne K Knecht; Kazu Kikuchi; Kenneth D Poss
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-15       Impact factor: 11.205

Review 2.  Intestinal stem cells and the colorectal cancer microenvironment.

Authors:  Bryan A Ong; Kenneth J Vega; Courtney W Houchen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

4.  Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21.

Authors:  Nirmalya Basu; Sayanti Saha; Imran Khan; Subbaraya G Ramachandra; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

5.  Polycomb Group Gene E(z) Is Required for Spermatogonial Dedifferentiation in Drosophila Adult Testis.

Authors:  Suk Ho Eun; Lijuan Feng; Luis Cedeno-Rosario; Qiang Gan; Gang Wei; Kairong Cui; Keji Zhao; Xin Chen
Journal:  J Mol Biol       Date:  2017-04-21       Impact factor: 5.469

6.  Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.

Authors:  A Shvab; G Haase; A Ben-Shmuel; N Gavert; T Brabletz; S Dedhar; A Ben-Ze'ev
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

7.  Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells.

Authors:  S Colak; J P Medema
Journal:  Cell Cycle       Date:  2016-06-17       Impact factor: 4.534

Review 8.  SLUG: Critical regulator of epithelial cell identity in breast development and cancer.

Authors:  Sarah Phillips; Charlotte Kuperwasser
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

9.  Earmuff restricts progenitor cell potential by attenuating the competence to respond to self-renewal factors.

Authors:  Derek H Janssens; Hideyuki Komori; Daniel Grbac; Keng Chen; Chwee Tat Koe; Hongyan Wang; Cheng-Yu Lee
Journal:  Development       Date:  2014-03       Impact factor: 6.868

10.  Hypoxia-inducible factors: a central link between inflammation and cancer.

Authors:  Daniel Triner; Yatrik M Shah
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.